医疗器械板块9月22日跌0.26%，浩欧博领跌，主力资金净流出6.84亿元

Core Insights - The medical device sector experienced a decline of 0.26% on September 22, with Haobor leading the drop [1] - The Shanghai Composite Index closed at 3828.58, up 0.22%, while the Shenzhen Component Index closed at 13157.97, up 0.67% [1] Medical Device Sector Performance - Notable gainers included: - Kangzhong Medical (688607) with a closing price of 31.73, up 10.14% and a trading volume of 59,500 shares, totaling 185 million yuan [1] - Rejing Bio (688068) closed at 181.84, up 4.57% with a trading volume of 31,100 shares, totaling 56.5 million yuan [1] - Zhend Medical (603301) closed at 41.11, up 2.90% with a trading volume of 119,900 shares, totaling 487 million yuan [1] - Major decliners included: - Haobor (688656) closed at 148.77, down 9.22% with a trading volume of 17,100 shares, totaling 26.5 million yuan [2] - Wuzhou Medical (301234) closed at 43.85, down 8.63% with a trading volume of 41,900 shares, totaling 186 million yuan [2] - Jiming Health (603222) closed at 12.47, down 6.45% with a trading volume of 801,100 shares, totaling 102.5 million yuan [2] Capital Flow Analysis - The medical device sector saw a net outflow of 684 million yuan from institutional investors, while retail investors contributed a net inflow of 847 million yuan [2][3] - Key stocks with significant capital flow included: - Mindray Medical (300760) with a net inflow of 79.43 million yuan from institutional investors [3] - Rejing Bio (688068) with a net inflow of 36.79 million yuan from institutional investors [3] - Wuzhou Medical (301234) had a net outflow of 28.64 million yuan from retail investors [3]